ARTICLE | Distillery Therapeutics
Cancer
August 16, 2018 4:10 PM UTC
Cell culture studies identified a triple KRAS/NRAS/HRAS inhibitor that could help treat KRAS-mutant colorectal cancer and NRAS-mutant non-small cell lung cancer (NSCLC). Screening of a small molecule ...
BCIQ Company Profiles